G
This company develops therapeutic cures for diseases with unmet needs using proprietary LgRNA-guided gene editing technology. They focus on scalable production of ultra-pure ligated single molecule guide RNAs (LgRNA) which offer enhanced efficacy and safety profiles. The platform is being applied to develop LgRNA-conjugate-directed CRISPR polymerase editing (STAR) therapeutics for conditions like neurodegenerative disorders and cancers.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- This company develops therapeutic cures for diseases with unmet needs using proprietary LgRNA-guided gene editing technology. They focus on scalable production of ultra-pure ligated single molecule guide RNAs (LgRNA) which offer enhanced efficacy and safety. The platform is being applied to develop LgRNA-conjugate-directed CRISPR polymerase editing (STAR) therapeutics for neurodegenerative disorders and cancers.